Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group-Reference-Cited by-同舟云学术

Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group

Published:2021-01-01 Issue:1 Volume:36 Page:2080-2086
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Linciano Pasquale¹,Pinzi Luca¹,Belluti Silvia¹,Chianese Ugo²,Benedetti Rosaria²,Moi Davide¹,Altucci Lucia²³^ORCID,Franchini Silvia¹,Imbriano Carol¹,Sorbi Claudia¹,Rastelli Giulio¹

Affiliation:

1. Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy

2. Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, Naples, Italy

3. Biogem Institute of Molecular and Genetic Biology, Ariano Irpino, Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Italian Ministry for University and Research

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2021.1981306

Reference28 articles.

1. Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates

2. Histone deacetylases: structural determinants of inhibitor selectivity

3. Development and therapeutic impact of HDAC6-selective inhibitors

4. Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight

5. The Lossen rearrangement from free hydroxamic acids

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer;European Journal of Medicinal Chemistry;2023-11

2. HDAC6: A unique HDAC family member as a cancer target;Cellular Oncology;2022-08-29

3. MiR-129-5p exerts Wnt signaling-dependent tumor-suppressive functions in hepatocellular carcinoma by directly targeting hepatoma-derived growth factor HDGF;Cancer Cell International;2022-05-16

4. Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ring;RSC Advances;2022

5. Anti-multiple myeloma potential of resynthesized belinostat derivatives: an experimental study on cytotoxic activity, drug combination, and docking studies;RSC Advances;2022